Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04105010 |
|
Recruitment Status :
Completed
First Posted : September 26, 2019
Last Update Posted : April 17, 2024
|
Sponsor:
Dizal Pharmaceuticals
Information provided by (Responsible Party):
Dizal Pharmaceuticals
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | October 12, 2023 |
| Actual Study Completion Date : | February 22, 2024 |